NLRP3 and autism: [85] demonstrated in their study using a maternal immune activation (MIA) mouse model of autism (C57BL/6) that maternal treatment with an NLRP3 antagonist (blocker) and a neutralizing IL‐1β antibody during pregnancy prevented the development of autistic traits in male offspring mice.